Swiss Government Confirms 13.5 Million COVID-19 Vaccine Order

Massachusetts-based Moderna, Inc. announced the Swiss Federal Government had increased its confirmed order commitment from 7.5 million to 13.5 million doses of the COVID-19 Vaccine Moderna in Switzerland.

The Swiss Federal Government's initial procurement for 4.5 million doses was announced on August 7, 2020, and was subsequently increased to 7.5 million doses on December 8, 2020. The additional 6 million doses announced today will be delivered beginning in the summer of 2021, with an option to receive doses in the first half of 2022 as Moderna explores potential vaccine boosters to address emerging variants.

On January 12, 2021, Swissmedic authorized the COVID-19 Vaccine Moderna, according to the ordinary approvals procedure and based on a rolling submission of data and the totality of scientific evidence shared by the Company, including a data analysis from the pivotal Phase 3 clinical study announced on November 30, 2020.

“We are grateful for the confidence and support showed by the Swiss Federal Government as they increase their supply agreement with us,” said Stéphane Bancel, Chief Executive Officer of Moderna, in a press statement.

The Moderna COVID-19 Vaccine (mRNA-1273) is an mRNA vaccine candidate against the novel coronavirus SARS-CoV-2 encoding for a prefusion stabilized form of the Spike (S) protein.